About the Foundation
Johan Jansson Foundation was established in November 3, 1997 by Kajsa and Harald Jansson and Susanne Hede in memory of their deceased son and husband. Johan Jansson died only 32 years old.
10 million SEK was donated to a fund for tumor research, and another fund of 2 million SEK was devoted to support cancer injured persons by providing specially adapted cars.
The fund is managed by a trust where Kajsa Jansson is the Chairman and her son’s wife Susanne Hede is a member of the Board, together with medical experts at the Medical Faculty at the Sahlgrenska University Hospital in Gothenburg.
Contributions to the Foundation
A financial contribution to the foundation may help to increased knowledge about the cancer area, which could ultimately lead to better opportunities for rapid diagnosis, cure and improved quality of life.
Tumor research and car subsidies
The Board of Johan Jansson Foundation has decided that the return will be used in supporting three specific activities, namely:
- To encourage scientific activities in the field of musculoskeletal tumor research in western Sweden, by awarding grants to research projects, and to national and international exchange of research information.
- Supporting the Centre for Musculoskeletal Tumor Research (CMT) at the Medical Faculty at Gothenburg University. CMT was formed in 1996 and the participants are representatives from the fields of orthopedics, pathology, adult and pediatric oncology and radiology. Activities are located at the Sahlgrenska University Hospital, and shall coordinate, streamline and enhance research facilities for this area of cancer research.
- Provide specially adapted cars for cancer injured persons in western Sweden, which themselves do not have the financial means to obtain such a car.
Car subsidies is primarily for persons who suffer from disability after musculoskeletal tumor surgery.
What is a musculoskeletal tumor?
Musculoskeletal tumors are cancers that affect the body’s locomotion and support tissues such as muscles, joints and bones. This form of cancer is relatively rare and primarily affects children and young adults.
Many of these tumors are very serious and they often requires difficult and extensive therapy including surgery, radiation therapy and pharmacological treatment.